China Pharma Holdings
CPHI
7 hedge funds and large institutions have $1.08M invested in China Pharma Holdings in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
17% more funds holding
Funds holding: 6 → 7 (+1)
3% more capital invested
Capital invested by funds: $1.04M → $1.08M (+$34K)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$14.4K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$7.39K |
| 3 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
+$3.44K |
Top Sellers
CPHI Hedge Fund Activity: Q2 2015 in Review
7 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q2 2015, worth a combined $1.08M — up 3.3% from $1.04M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CPHI positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $14.4K. The largest seller was First Wilshire Securities Management, cutting an estimated $42.6K.
- 7 institutional investors held China Pharma Holdings (CPHI) as of Q2 2015, up from 6 in Q1 2015.
- Funds reported $1.08M of China Pharma Holdings stock for Q2 2015, up 3.3% quarter-over-quarter.
- 3 funds opened new China Pharma Holdings positions in Q2 2015 and 2 closed out, a net change of +1 holder.
- The largest China Pharma Holdings buyer in Q2 2015 was Citadel Advisors, an estimated $14.4K added.
- The largest China Pharma Holdings seller in Q2 2015 was First Wilshire Securities Management, an estimated $42.6K sold.
Based on aggregated 13F filings for Q2 2015.